NORTHERN TRUST CORP - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$15,811,372
-9.3%
1,641,887
+0.2%
0.00%0.0%
Q2 2023$17,434,905
+1.1%
1,638,619
+0.0%
0.00%0.0%
Q1 2023$17,237,494
-14.7%
1,638,545
+0.5%
0.00%
-25.0%
Q4 2022$20,202,874
+24.8%
1,630,579
+4.4%
0.00%0.0%
Q3 2022$16,183,000
-14.4%
1,562,093
-4.7%
0.00%0.0%
Q2 2022$18,896,000
-7.4%
1,638,893
+1.1%
0.00%0.0%
Q1 2022$20,397,000
+3.9%
1,621,340
-3.7%
0.00%
+33.3%
Q4 2021$19,628,000
-13.1%
1,683,370
-2.6%
0.00%
-25.0%
Q3 2021$22,579,000
+1.4%
1,728,883
-0.1%
0.00%0.0%
Q2 2021$22,271,000
+7.4%
1,730,416
-6.7%
0.00%0.0%
Q1 2021$20,735,000
-7.9%
1,854,700
-6.2%
0.00%0.0%
Q4 2020$22,512,000
+22.8%
1,976,431
-3.0%
0.00%0.0%
Q3 2020$18,335,000
-17.9%
2,038,249
-5.8%
0.00%
-20.0%
Q2 2020$22,321,000
+8.0%
2,162,983
+5.6%
0.01%
-16.7%
Q1 2020$20,660,000
-22.4%
2,047,538
+2.3%
0.01%0.0%
Q4 2019$26,628,000
+58.5%
2,000,626
+2.2%
0.01%
+50.0%
Q3 2019$16,804,000
-14.1%
1,957,355
+9.5%
0.00%
-20.0%
Q2 2019$19,555,000
-17.6%
1,787,453
+1.9%
0.01%
-16.7%
Q1 2019$23,732,000
+33.8%
1,753,995
+2.4%
0.01%
+20.0%
Q4 2018$17,738,000
-42.8%
1,712,129
+2.0%
0.01%
-37.5%
Q3 2018$30,997,000
-1.3%
1,679,122
+2.3%
0.01%0.0%
Q2 2018$31,392,000
+30.3%
1,641,866
+5.1%
0.01%
+33.3%
Q1 2018$24,099,000
+3.2%
1,561,766
+0.3%
0.01%0.0%
Q4 2017$23,342,000
-7.6%
1,557,153
-2.8%
0.01%
-14.3%
Q3 2017$25,265,000
-17.6%
1,602,082
-1.4%
0.01%
-22.2%
Q2 2017$30,667,000
+17.0%
1,624,268
+5.8%
0.01%
+12.5%
Q1 2017$26,201,000
+13.4%
1,535,804
+1.7%
0.01%
+14.3%
Q4 2016$23,098,000
-17.6%
1,510,621
-14.4%
0.01%
-22.2%
Q3 2016$28,035,000
+21.2%
1,765,420
-0.2%
0.01%
+12.5%
Q2 2016$23,122,000
+22.6%
1,768,413
+1.7%
0.01%
+33.3%
Q1 2016$18,864,000
-4.8%
1,739,598
+1.8%
0.01%
-14.3%
Q4 2015$19,808,000
+13.7%
1,709,052
+2.2%
0.01%
+16.7%
Q3 2015$17,417,000
+12.8%
1,671,538
+30.5%
0.01%
+20.0%
Q2 2015$15,444,000
-40.5%
1,280,587
-21.1%
0.01%
-37.5%
Q1 2015$25,959,000
+6.1%
1,622,430
+1.6%
0.01%
+14.3%
Q4 2014$24,469,000
+13.6%
1,597,172
-3.9%
0.01%0.0%
Q3 2014$21,535,000
+8.0%
1,662,370
+27.8%
0.01%
+16.7%
Q2 2014$19,938,000
-6.4%
1,300,625
-24.8%
0.01%
-14.3%
Q1 2014$21,299,000
+36.8%
1,728,862
+29.0%
0.01%
+40.0%
Q4 2013$15,565,000
-0.6%
1,340,678
+1.4%
0.01%
-16.7%
Q3 2013$15,654,000
+27.6%
1,322,175
+7.0%
0.01%
+50.0%
Q2 2013$12,272,0001,235,9980.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$188,977,00019.02%
13D Management LLC 600,431$6,923,0003.06%
BRIDGER MANAGEMENT, LLC 956,014$11,023,0002.48%
Brown Capital Management 11,641,935$134,232,0001.80%
Price Jennifer C. 520,000$5,996,0001.02%
Monarch Partners Asset Management LLC 272,425$3,141,0000.88%
ALPHASIMPLEX GROUP, LLC 10,510$121,0000.86%
Intrinsic Value Partners, LLC 54,105$624,0000.80%
CLARK ESTATES INC/NY 355,000$4,093,0000.71%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 692$60,000,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders